What we do
We partner with entrepreneurs, managers and investors to help them build successful companies by providing flexible capital and business development solutions
30+
Years in the market
36
Transactions closed
€2bn
Invested
Flexible Capital Solutions
€10m – €100m
- Buyout equity
- Minority equity investments
- Equity injections and development capital
- Hybrid capital solutions
- Preference shares
Corporate Development Services
Advisory and Support
- Corporate development
- Build-ups and roll-outs
- Internationalization
- Rationalization and operational improvements
- Professionalization and succession plans
- Balance sheet restructuring and recap
Latest news
May 15, 2026
Strategic Partnership Between GIAS and VIS
GIAS has entered into a strategic partnership with VIS, announced during Tuttofood 2026, to support commercial growth,…
November 25, 2025
Lexer at CMS Finance Week 2025
Strong takeaways from #CMSFinanceWeek2025, where LEXER stood out in key discussions on the future of LegalTech.
November 5, 2025
Cleon Capital acquires Lexer and Zelsior
Continuing our mission to build leaders in Southern Europe, we’re integrating LEXER and ZELSIOR to form Spain’s leading…
October 27, 2025
Cocoon Bioscience launches its T4 DNA Ligase
We’re thrilled to share that Cocoon Bioscience has launched its T4 DNA Ligase, a high-purity (≥95%) and cost-effective…



